Ultragenyx Pharmaceutical Inc. buy Robert W. Baird
Start price
31.05.24
/
50%
€36.00
Target price
31.05.25
€66.15
Performance (%)
-17.78%
End price
01.06.25
€29.60
Summary
This prediction ended on 01.06.25 with a price of €29.60. The prediction for Ultragenyx Pharmaceutical Inc. disappointed with a performance of -17.78%. Robert_W__Baird has a follow-up prediction for Ultragenyx Pharmaceutical Inc. where he still thinks Ultragenyx Pharmaceutical Inc. is a Buy. Robert_W__Baird has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 2.083% | 2.083% | -51.000% |
| iShares Core DAX® | -0.383% | 2.613% | 11.343% |
| iShares Nasdaq 100 | -0.411% | -2.005% | 5.353% |
| iShares Nikkei 225® | 1.838% | 9.391% | 33.529% |
| iShares S&P 500 | -0.712% | -0.476% | 2.508% |
Comments by Robert_W__Baird for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) had its price target raised by analysts at Robert W. Baird from $68.00 to $72.00. They now have an "outperform" rating on the stock.
Ratings data for RARE provided by MarketBeat
In the thread Trading Ultragenyx Pharmaceutical Inc.
Die von Robert_W__Baird gewählte maximale Laufzeit wurde überschritten
Current prediction by Robert_W__Baird for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€17.00
30.12.25
30.12.25
€39.91
30.12.26
30.12.26
14.71%
08:48
08:48
Stopped prediction by Robert_W__Baird for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€40.80
30.01.24
30.01.24
€62.74
30.01.25
30.01.25
1.96%
31.01.25
31.01.25